NovaBay Pharmaceuticals Accounts Receivable:
0.916M for March 31, 2013NovaBay Pharmaceuticals Historical Accounts Receivable Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 0.916M |
| Dec. 31, 2012 | 0.943M |
| Sept. 30, 2012 | 0.126M |
| June 30, 2012 | 0.009M |
| March 31, 2012 | 1.009M |
| Dec. 31, 2011 | 0.003M |
| Sept. 30, 2011 | 1.825M |
| June 30, 2011 | 3.566M |
| March 31, 2011 | 0.00 |
| Dec. 31, 2010 | 0.50M |
| Sept. 30, 2010 | |
| June 30, 2010 | |
| March 31, 2010 | |
| Dec. 31, 2009 | 3.75M |
| Sept. 30, 2009 | |
| June 30, 2009 | |
| March 31, 2009 | |
| Dec. 31, 2008 | 0.00 |
About Accounts Receivable
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
YCharts takes accounts receivable from the balance sheet of a company. It is reported net of allowance for bad debts.
Learn More
NBY Accounts Receivable Benchmarks
| Companies | |
|---|---|
| Momenta Pharmaceuticals | 5.396M |
| Ligand Pharmaceuticals | 4.589M |
| Sagent Pharmaceuticals | 35.84M |
NBY Accounts Receivable Rankings
| Overall |
58th percentile 3357 of 8007 |
| Sector |
46th percentile 369 of 685 in Healthcare |
| Industry |
47th percentile 36 of 68 in Drug Manufacturers - Specialty & Generic |
NBY Accounts Receivable Range, Past 5 Years
| Minimum | 0.00 | Dec 2008 |
| Maximum | 3.75M | Dec 2009 |
| Average | 1.054M |
